Syndax Pharmaceuticals (SNDX) Finished Goods (2024 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Finished Goods of $1.4 million for Q1 2026, up 1284.0% year-over-year from $100000.0 in Q1 2025, and down 14.3% quarter-over-quarter from $1.6 million in Q4 2025.
Syndax Pharmaceuticals (SNDX) Finished Goods (2024 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Finished Goods history runs 3 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Finished Goods rose 1284.0% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 1284.0% YoY), while the FY2025 annual figure was $1.6 million, up 4386.11% from the prior year.
- Finished Goods for Q1 2026 stood at $1.4 million, down from $1.6 million in the prior quarter.
- The five-year high for Finished Goods was $2.2 million in Q2 2025, with the low at $36000.0 in Q4 2024.
- The 3-year median for Finished Goods is $1.5 million (2025), against an average of $1.3 million.
- The sharpest annual moves came in 2025 and 2026: Finished Goods soared 4386.11% in 2025, then surged 1284.0% in 2026.
- Syndax Pharmaceuticals' Finished Goods stood at $36000.0 in 2024, then jumped by 4386.11% to $1.6 million in 2025, then slipped by 14.3% to $1.4 million in 2026.
- Business Quant data shows SNDX's Finished Goods at $1.4 million in Q1 2026, $1.6 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Sep 30, 2025 | 2.22 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 36,000.00 |